Difference between revisions of "Alexander Denoon"
(→Background) |
(→Background) |
||
| Line 20: | Line 20: | ||
:2001–2003 (2 years) | :2001–2003 (2 years) | ||
| − | General Counsel and Company Secretary, Biotech Australia | + | :General Counsel and Company Secretary, Biotech Australia |
:1998–2001 (3 years) | :1998–2001 (3 years) | ||
| Line 35: | Line 35: | ||
:LLB | :LLB | ||
:1988–1994 | :1988–1994 | ||
| + | |||
| + | ==Affiliations== | ||
| + | According to his LinkedIn page, his "groups and associations" include groups associated with stem cell research, gene therapy and intellectual property (patents): cell therapy industry group, cellfate, ELSI subgroup, and intellectual property professionals.<ref>LinkedIn, [http://www.linkedin.com/pub/alex-denoon/22/334/30b Alexander Denoon], acc 26 Nov 2012</ref> | ||
==Contact== | ==Contact== | ||
Revision as of 16:38, 27 November 2012
Alexander Denoon is a lawyer and the owner of the London-based law practice Lawford Davies Denoon.[1]
Denoon has a BSc in human genetics and from 1998-2001 was general counsel and company secretary of Biotech Australia.[2][3]
Background
From his LinkedIn page as at November 2012:[4]
- Owner, Lawford Davies Denoon
- November 2009–Present (3 years 1 month)
- Senior Associate, Clifford Chance
- Partnership; 5001-10,000 employees; Law Practice industry
- May 2005–November 2009 (4 years 7 months)
- Special Adviser to the Board, Silverbrook Research
- Privately Held; 201-500 employees; Research industry
- 2003–2004 (1 year)
- General Counsel and Company Secretary, Redfern Broadband Networks
- 2001–2003 (2 years)
- General Counsel and Company Secretary, Biotech Australia
- 1998–2001 (3 years)
- Solicitor, Freehills
- Partnership; 1001-5000 employees; Law Practice industry
- 1995–1998 (3 years)
- Education
- University of New South Wales
- BSc, Human Genetics
- 1988–1994
- University of New South Wales
- LLB
- 1988–1994
Affiliations
According to his LinkedIn page, his "groups and associations" include groups associated with stem cell research, gene therapy and intellectual property (patents): cell therapy industry group, cellfate, ELSI subgroup, and intellectual property professionals.[5]
Contact
- Address:
- ...
- ...
- ...
- ...
- Phone:
- ...
- Email:
- ...
- Website:
- ...
Resources
Notes
- ↑ LinkedIn, Alexander Denoon, acc 26 Nov 2012
- ↑ Lawford Davies Denoon (2012) Alexander Denoon, acc 3 Oct 2012
- ↑ LinkedIn, Alexander Denoon, acc 3 Oct 2012
- ↑ LinkedIn, Alexander Denoon, acc 26 Nov 2012
- ↑ LinkedIn, Alexander Denoon, acc 26 Nov 2012
